Back

Impact of antidiabetic treatment on mortality and heart failure readmissions: beyond hipoglucemic effect

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Risk factors and prevention Diabetes and the Heart HFA Premium Access Heart Failure 2019

About the speaker

Photo
Ms Laura Rodriguez

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

11 More presentations in this session

Presentation thumbnail
Asian Diabetes Outcome Prevention Trial (ADOPT)
Doctor C. Chandramouli (Singapore, SG)
Abstract
Presentation thumbnail
Combined therapy with rosuvastatin and ezetimibe on inflammatory state and pro-inflammatory cytokines in patients with coronary heart disease and metabolic syndrome
Doctor J. Uzokov (Tashkent, UZ)
Abstract
Presentation thumbnail
Nesfatin-1 activity in hypertensive obese patients changes with the duration of hypertension
Associate Professor M. Vizir (Kharkiv, UA)
Abstract Slides
Presentation thumbnail
Anthropometric measurements of central adiposity are superior predictors of heart failure in the general population - data of PREVEND
Assistant Professor N. Suthahar (Rotterdam, NL)
Presentation thumbnail
Diabetes mellitus is a predictor of development of heart failure independent of HTN, CAD and diastolic function: a population based study
Professor H. Chen (Rochester, US)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Risk factors and prevention

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
Cardiovascular risk reduction: should we target pre-diabetes?
thumbnail
Congress Presentation
Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting
thumbnail
Congress Presentation
Diabetes as a major comorbidity in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources